Authors:
van Sandick, JW
van Lanschot, JJB
ten Kate, FJW
Offerhaus, GJA
Fockens, P
Tytgat, GNJ
Obertop, H
Citation: Jw. Van Sandick et al., Pathology of early invasive adenocarcinoma of the esophagus or esophagogastric junction - Implications for therapeutic decision making, CANCER, 88(11), 2000, pp. 2429-2437
Authors:
Boeckxstaens, GE
Hollmann, M
Heisterkamp, SH
Robberecht, P
de Jonge, WJ
van den Wijngaard, RMJGJ
Tytgat, GNJ
Blommaart, PJE
Citation: Ge. Boeckxstaens et al., Evidence for VIP1/PACAP receptors in the afferent pathway mediating surgery-induced fundic relaxation in the rat, BR J PHARM, 131(4), 2000, pp. 705-710
Authors:
Vaira, D
Malfertheiner, P
Megraud, F
Axon, ATR
Deltenre, M
Gasbarrini, G
O'Morain, C
Garcia, JMP
Quina, M
Tytgat, GNJ
Citation: D. Vaira et al., Noninvasive antigen-based assay for assessing Helicobacter pylori eradication: A European multicenter study, AM J GASTRO, 95(4), 2000, pp. 925-929
Authors:
Polkowski, W
van Lanschot, JJB
ten Kate, FJW
Rolf, TM
Polak, M
Tytgat, GNJ
Obertop, H
Offerhaus, GJA
Citation: W. Polkowski et al., Intestinal and pancreatic metaplasia at the esophagogastric junction in patients without Barrett's esophagus, AM J GASTRO, 95(3), 2000, pp. 617-625
Authors:
de Boer, WA
van Etten, RJXM
Schneeberger, PM
Tytgat, GNJ
Citation: Wa. De Boer et al., A single drug for Helicobacter pylori infection: First results with a new bismuth triple monocapsule, AM J GASTRO, 95(3), 2000, pp. 641-645
Authors:
Boeckxstaens, GE
Hirsch, DP
Kodde, A
Moojen, TM
Blackshaw, A
Tytgat, GNJ
Blommaart, PJE
Citation: Ge. Boeckxstaens et al., Activation of an adrenergic and vagally-mediated NANC pathway in surgery-induced fundic relaxation in the rat, NEUROG MOT, 11(6), 1999, pp. 467-474
Authors:
de Wit, AWMV
Kuiper, H
Camoglio, L
van Bracht, J
Jones, EA
Tytgat, GNJ
van Deventer, SJH
Citation: Awmv. De Wit et al., Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?, EUR J GASTR, 11(2), 1999, pp. 129-136
Citation: Gnj. Tytgat, Biliopancreatic malignancy: From gene to cure - 4-6 February 1999 - Academic Medical Center, Amsterdam, The Netherlands - Introduction, ANN ONCOL, 10, 1999, pp. VII-VII
Authors:
Cooreman, MP
van Roosmalen, VH
Morsche, RT
Sunnen, CMG
Schoondermark-Van de Ven, EME
Jansen, JBMJ
Tytgat, GNJ
de Wit, PLM
Paulij, WP
Citation: Mp. Cooreman et al., Characterization of the reactivity pattern of murine monoclonal antibodiesagainst wild-type hepatitis B surface antigen to G145R and other naturallyoccurring "a" loop escape mutations, HEPATOLOGY, 30(5), 1999, pp. 1287-1292
Authors:
Van der Hulst, RWM
Lamouliatte, H
Megraud, F
Pounder, RE
Stoltes, M
Vaira, D
Williams, M
Tytgat, GNJ
Citation: Rwm. Van Der Hulst et al., Laser assisted ratio analyser C-13-urea breath testing, for the detection of H-pylori: a prospective diagnostic European multicentre study, ALIM PHARM, 13(9), 1999, pp. 1171-1177
Authors:
Houben, MHMG
Van de Beek, D
Hensen, EF
De Craen, AJM
Rauws, EAJ
Tytgat, GNJ
Citation: Mhmg. Houben et al., A systematic review of Helicobacter pylori eradication therapy - the impact of antimicrobial resistance on eradication rates, ALIM PHARM, 13(8), 1999, pp. 1047-1055
Authors:
Houben, MHMG
Hensen, EF
Rauws, EAJ
Van der Hulst, RWM
Van't Hoff, BWM
Van der Ende, A
Ten Kate, FJW
Tytgat, GNJ
Citation: Mhmg. Houben et al., Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains, ALIM PHARM, 13(7), 1999, pp. 883-889
Citation: Sd. Xiao et al., High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week, ALIM PHARM, 13(3), 1999, pp. 311-315
Authors:
Liu, WZ
Xiao, SD
Shi, Y
Wu, SM
Zhang, DZ
Xu, WW
Tytgat, GNJ
Citation: Wz. Liu et al., Furazolidone-containing short-term triple therapies are effective in the treatment of Helicobacter pylori infection, ALIM PHARM, 13(3), 1999, pp. 317-322